Widely-used hormone drug associated with increased risk of benign brain tumor at high doses

High doses of a widely-used drug used in the hormonal treatment of conditions such as excessive hair growth, early puberty, prostate cancer, are linked to an increased risk of meningioma -- the most common type of benign brain tumor, finds a new study of over 8-million patients.